These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6061057)
1. [Antisecretory activity of some new compounds without anticholinergic activity]. Rovati AL; Casula PL; Da Re G Minerva Med; 1967 Oct; 58(86):3651-3. PubMed ID: 6061057 [No Abstract] [Full Text] [Related]
2. [Pharmacological and clinical evaluation of a new non-anticholinergic antisecretory substance]. Rovati AL; Casula PL; Lepori L; Da Re G Minerva Med; 1967 Oct; 58(86):3653-6. PubMed ID: 6061058 [No Abstract] [Full Text] [Related]
3. [Pharmacology and experimental toxicology of a new non-anticholinergic product with antisecretory and gastroprotective activity (CR 242, xylamide-Milid)]. Rovati AL; Casula PL; Da Re G Minerva Med; 1967 Oct; 58(86):3656-70. PubMed ID: 6061059 [No Abstract] [Full Text] [Related]
4. [Action of xylamide, CR 242, on gastric secretion of dogs after hypersecretory stimuli]. Danhof IA Minerva Med; 1967 Oct; 58(86):3670-7. PubMed ID: 6061060 [No Abstract] [Full Text] [Related]
5. [Clinical evaluation, in gastritis and gastroduodenal ulcers of a new non-anticholinergic compound with protective and antisecretory activity]. Fantino M; Roccia L Minerva Med; 1967 Oct; 58(86):3677-85. PubMed ID: 6061061 [No Abstract] [Full Text] [Related]
6. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)]. Mainoli S; Milvio C; Borellini D Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066 [No Abstract] [Full Text] [Related]
7. [Clinical considerations on the therapeutic effect of a new non-anticholinergic antisecretory preparation: Milid (xylamide, CR 242)]. Castelli CA; Locatelli L; Salvioni GF Minerva Med; 1967 Oct; 58(86):3704-8. PubMed ID: 6061065 [No Abstract] [Full Text] [Related]
8. [Pharmacological investigation of a new synthesized antacid-Hydrotalcite (H-505) and its related substances. Investigation of their influence on artificial gastric juice and experimental gastric ulcer]. Hara S; Hirayama H; Itabashi H; Sasaki Y; Matsushima Y Zasshi Tokyo Ika Daigaku; 1968 Mar; 26(1):211-26. PubMed ID: 5692514 [No Abstract] [Full Text] [Related]
9. [Antisecretory therapeutic activity of Milid (xylamide, CR 242) in the treatment of gastroduodenal ulcer]. Giordano G; Comi L Minerva Med; 1967 Oct; 58(86):3688-91. PubMed ID: 6061062 [No Abstract] [Full Text] [Related]
10. [Signs of tolerability in man, clinical pharmacology and activity of a new non-anticholinergic product active in gastroduodenitis and gastroduodenal ulcer (Milid)]. Casone A; Borellini D; Jezzi B Minerva Med; 1967 Oct; 58(86):3699-704. PubMed ID: 6061064 [No Abstract] [Full Text] [Related]
11. [Action of antacids in vitro]. Balanzo J; Cusso X; Sureda D; Vilardell F Rev Clin Esp; 1979 Jan; 152(2):141-2. PubMed ID: 441461 [No Abstract] [Full Text] [Related]
12. [Gastroprotective activity of a new substance (xylamide, Milid) in gastric disorders secondary to administration of corticoids]. Gobbi F Minerva Med; 1967 Oct; 58(86):3685-8. PubMed ID: 5183197 [No Abstract] [Full Text] [Related]
13. [Intragastric determination of neutralization capacity of antacids]. Becker HD; Degenhardt T; Loweg C Z Gastroenterol; 1983 Mar; 21 Suppl():26-32. PubMed ID: 6858408 [No Abstract] [Full Text] [Related]
14. [Medical treatment of bleeding ulcers: the effects of antacid neutralization of pH 7 of gastric juice]. Hostein J; Fournet J; Meullenet J; Bonnet-Eymard J Gastroenterol Clin Biol; 1982; 6(8-9):638-45. PubMed ID: 6751922 [No Abstract] [Full Text] [Related]
15. The antisecretory and antipeptic activity of gastric antacids in the histamine-stimulated rabbit. PACKMAN EW; ABBOTT DD; TRABIN B; HARRISSON JW J Am Pharm Assoc Am Pharm Assoc; 1959 Jan; 48(1):46-9. PubMed ID: 13610731 [No Abstract] [Full Text] [Related]
16. [Gastrin]. Guerre J Sem Hop; 1966 Oct; 42(43):2561-3. PubMed ID: 4291412 [No Abstract] [Full Text] [Related]
17. Evaluating antacids. Fisher JR N Z Med J; 1969 May; 69(444):320-1. PubMed ID: 5256213 [No Abstract] [Full Text] [Related]
18. [Evaluation of the neutralizing capacity in vitro of some typified antacid preparations]. Pastia A; Caba M; GafiĊ£anu E; Matei I Rev Med Chir Soc Med Nat Iasi; 1978; 82(1):123-5. PubMed ID: 674940 [No Abstract] [Full Text] [Related]
19. [An ambivalent product normalizing gastric pH; application of a telemetric method (Heidelberg's capsule)]. Truchaud M; Gazave JM; Page M Ann Pharm Fr; 1975; 33(6-7):313-9. PubMed ID: 4005 [No Abstract] [Full Text] [Related]
20. In vitro comparison of acid-consuming capacity and duration of action of antacids. Packman EW; Gennaro AR Am J Pharm Sci Support Public Health; 1973; 145(5):162-4. PubMed ID: 4753131 [No Abstract] [Full Text] [Related] [Next] [New Search]